Focus: In an effort to keep the patient centered in conversations about digital therapeutics, DTA and its members seek to define best-in-class standards for involving the patient in the development and launch of digital therapeutics, and to uncover barriers to their adoption by patients, payers, and regulatory bodies worldwide.
Tim Campellone
Vice President, Translational Science
Woebot Health
Cate Layne
Director, Brand & Communications
Propeller Health